CWY-10366-25257
1 vaccination
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 065 / CT
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Moderna
- 2021-01-14
- 2021-01-15
- 2021-01-17
-
2022-01-14
Survey response — 12 months, dose 1MedDRA: Diarrhoea, Dizziness, Fatigue, Headache, Nausea, Tinnitus — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Ringing in the ear, Diarrhea, headache, dizziness, nauseous and fatigue.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Moderna |
Free text
Release 10 — 12 months, dose 1
Symptoms: Ringing in the ear, Diarrhea, headache, dizziness, nauseous and fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Tinnitus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release